Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

The best heart hospitals in the United States

U.S. News & World Report has released its annual ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. Did your facility make the cut this year?

Thumbnail

ICD patients may experience fear, anxiety or depression due to their devices

Some patients feel anxiety due to the risk of being shocked. Others have device recalls and/or cybersecurity threats on their mind.

Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.

CCTA could make invasive angiography a thing of the past

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 

Stereotaxis MAGIC SWEEP electrophysiology catheter

FDA clears first robotically guided EP mapping catheter for ablation

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

Thumbnail

The pandemic accelerated brain aging, even in those who never contracted COVID

The new data is prompting questions about how stress, isolation and the disruption of normal routines affect the brain on a physiological level. 

pharmaceutical drug approval process

New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful. 

Larry Wood

Edwards Lifesciences loses TAVR leader to robotics firm, announces replacement

The change comes at a momentous time for the company's TAVR portfolio, which made history in May by receiving the very first FDA approval for treating asymptomatic severe AS.

Thumbnail

How drinking habits influence heart health

Prior studies have already evaluated how individual drinks affect the heart—but what about a person's beverage choices over an extended period of time?